Copyright © 2001 by the European Society of Cardiology.
Editorials
The heart failure epidemic: exactly how big is it?
Department of Cardiology, University of Hull, Kingston upon Hull, U.K.
References
- Eur Heart J. 1997;18:736–753
[Free Full Text] - Cleland JGF, Erdmann E, Ferrari R. Guidelines for the diagnosis of heart failure. Eur Heart J. 1995;16:741–751
[Free Full Text] - Cleland JGF, Gemmel I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Failure. 1999;1:229–241[CrossRef][Web of Science][Medline]
- Cleland JGF. Screening for left ventricular dysfunction and chronic heart failure: Should it be done and, if so, how. Disease Management Review (ADIS press). 1998;1:11–26
- Cowie MR, Mosterd A, Wood DA. The epidemiology of heart failure. Eur Heart J. 1997;18:208–223
[Free Full Text] - Hedberg P, Lönnberg I, Jonason T, Nilsson G, Pehrsson K, Ringqvist I. Left ventricular systolic dysfunction in 75-year-old men and women; a population-based study. Eur Heart J. 2001;22:676–683
[Abstract/Free Full Text] - McDonagh TA, Morrison CE, Lawrence A. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997;350:829–833[CrossRef][Web of Science][Medline]
- McDonagh T, Robb SD, Murdoch DR. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998;351:9–13[CrossRef][Web of Science][Medline]
- Cleland JGF, Ward S, Dutka D, Habib F, Impallomeni M, Morton IJ. Stability of plasma concentrations of N and C-terminal atrial natriuretic peptides at room temperature. Heart. 1996;75:410–413
[Abstract/Free Full Text] - Cleland JGF. Diagnosis of heart failure. Heart. 1998;79:S10–S16[Web of Science][Medline]
- Remes J, Miettinen H, Reunanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J. 1991;12:315–321
[Abstract/Free Full Text] - Gillespie ND, McNeill G, Pringle T, Ogston S, Struthers AD, Pringle SD. Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea. BMJ. 1997;314:936–940
[Abstract/Free Full Text] - Pfeffer MA, Braunwald E, Moye LA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction—Results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669–677[Abstract]
- Yusuf S, Nicklas JM, Timmis G. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–691[Abstract]
- Brockell U, Hense HW, Muscholl M, Doring A, Riegger GA, Schunkert H. Prevalence of left ventricular dysfunction in the general population (Abstr). J Am Coll Cardiol. 1996;27:25A
- Mosterd A, de Bruijne MC, Hoes AW, Deckers JW, Hofman A, Grobbee DE. Usefulness of echocardiography in detecting left ventricular dysfunction in population based studies (The Rotterdam Study). Am J Cardiol. 1997;79:103–104[CrossRef][Web of Science][Medline]
- Cleland JGF, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet. 1998;352:st19–st28
- Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J. 1994;71:584–587
[Abstract/Free Full Text] - Caruana L, Petrie MC, Davie AP, McMurray JV. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from ‘diastolic heart failure’ or from misdiagnosis? A prospective descriptive study. BMJ. 2000;321:215–218
[Abstract/Free Full Text] - Cleland J, Swedberg K, Cohen Solal A. The EuroHeart Failure Survey of the EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe. Eur J Heart Failure. 2000;2:123–132
[Abstract/Free Full Text] - Eur J Heart Failure. 1999;1:139–144
[Abstract/Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Lapp, V. Mitrovic, N. Franz, H. Heuer, M. Buerke, J. Wolfertz, W. Mueck, S. Unger, G. Wensing, and R. Frey Cinaciguat (BAY 58-2667) Improves Cardiopulmonary Hemodynamics in Patients With Acute Decompensated Heart Failure Circulation, June 2, 2009; 119(21): 2781 - 2788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Verdecchia, F. Angeli, C. Cavallini, R. Gattobigio, G. Gentile, J. A. Staessen, and G. Reboldi Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis Eur. Heart J., March 2, 2009; 30(6): 679 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Erhardt, M. Komajda, F.D. R. Hobbs, and J. Soler-Soler Cardiologists' awareness and perceptions of guidelines for chronic heart failure. The ADDress your Heart survey Eur J Heart Fail, October 1, 2008; 10(10): 1020 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E D Nicol, B Fittall, M Roughton, J G F Cleland, H Dargie, and M R Cowie NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland Heart, February 1, 2008; 94(2): 172 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Das Apoptosis as a therapeutic target in heart failure Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1322 - H1323. [Full Text] [PDF]
|
|
|
|
|
|
D. Mozaffarian, S. D. Anker, I. Anand, D. T. Linker, M. D. Sullivan, J. G.F. Cleland, P. E. Carson, A. P. Maggioni, D. L. Mann, B. Pitt, et al. Prediction of Mode of Death in Heart Failure: The Seattle Heart Failure Model Circulation, July 24, 2007; 116(4): 392 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Herrmann, O. Taban-Shoma, U. Hubner, A. Pexa, H. Kilter, N. Umanskaya, R. Hans Straub, M. Bohm, and W. Herrmann Hyperhomocysteinemia and Myocardial Expression of Brain Natriuretic Peptide in Rats Clin. Chem., April 1, 2007; 53(4): 773 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lainscak, J. G.F. Cleland, M. J. Lenzen, F. Follath, M. Komajda, and K. Swedberg International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: Data from the EuroHeart Failure Survey Eur J Heart Fail, March 1, 2007; 9(3): 292 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Herrmann, S. Muller, I. Kindermann, L. Gunther, J. Konig, M. Bohm, and W. Herrmann Plasma B vitamins and their relation to the severity of chronic heart failure Am. J. Clinical Nutrition, January 1, 2007; 85(1): 117 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. White, R. Yee, X. Yuan, A. Krahn, A. Skanes, M. Parker, G. Klein, and M. Drangova Delayed Enhancement Magnetic Resonance Imaging Predicts Response to Cardiac Resynchronization Therapy in Patients With Intraventricular Dyssynchrony J. Am. Coll. Cardiol., November 21, 2006; 48(10): 1953 - 1960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Huerta, C Varas-Lorenzo, J Castellsague, and L A Garcia Rodriguez Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population Heart, November 1, 2006; 92(11): 1610 - 1615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Herrmann, O. Taban-Shomal, U. Hubner, M. Bohm, and W. Herrmann A review of homocysteine and heart failure Eur J Heart Fail, October 1, 2006; 8(6): 571 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Biagini, M. Valgimigli, P. C. Smits, D. Poldermans, A. F.L. Schinkel, V. Rizzello, E. E.M. Onderwater-, M. Bountioukos, and P. W. Serruys Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischaemic heart failure Eur J Heart Fail, October 1, 2006; 8(6): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lainscak and I. Keber Patients' knowledge and beta blocker treatment improve prognosis of patients from a heart failure clinic Eur J Heart Fail, March 1, 2006; 8(2): 187 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R J Shelton, A S Rigby, J G F Cleland, and A L Clark Effect of a community heart failure clinic on uptake of {beta} blockers by patients with obstructive airways disease and heart failure Heart, March 1, 2006; 92(3): 331 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. McAlister, J. V. Tu, A. Newman, D. S. Lee, S. Kimber, B. Cujec, and P. W. Armstrong How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts Eur. Heart J., February 1, 2006; 27(3): 323 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Sturm, F. M. Haaijer-Ruskamp, N. J. Veeger, C. P. Balje-Volkers, K. Swedberg, and W. H. van Gilst The relevance of comorbidities for heart failure treatment in primary care: A European survey Eur J Heart Fail, January 1, 2006; 8(1): 31 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.D. R. Hobbs, J. Korewicki, J. G.F. Cleland, J. Eastaugh, N. Freemantle, and on behalf of the IMPROVEMENT Investigators The diagnosis of heart failure in European primary care: The IMPROVEMENT Programme survey of perception and practice Eur J Heart Fail, August 1, 2005; 7(5): 768 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.E. Haworth, E. Moniz-Cook, A.L. Clark, M. Wang, R. Waddington, and J.G.F. Cleland Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction Eur J Heart Fail, August 1, 2005; 7(5): 803 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. P.M. van Empel, A. T.A. Bertrand, L. Hofstra, H. J. Crijns, P. A. Doevendans, and L. J. De Windt Myocyte apoptosis in heart failure Cardiovasc Res, July 1, 2005; 67(1): 21 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, K. Swedberg, Writing Committee:, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. A. Smiseth, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur. Heart J., June 1, 2005; 26(11): 1115 - 1140. [Full Text] [PDF]
|
|
|
|
|
|
A. Schuchert and On behalf of the BISEX Investigators (Appendix A) Effects of bisoprolol treatment for chronic heart failure initiated and followed up by primary care physicians Eur J Heart Fail, June 1, 2005; 7(4): 604 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G.F. Cleland Patients with treatable malignant diseases -- including heart failure -- are entitled to specialist care Can. Med. Assoc. J., January 18, 2005; 172(2): 207 - 209. [Full Text] [PDF]
|
|
|
|
|
|
J. G.F. Cleland, K. Goode, and K. Lalukota Diagnosing heart failure in primary care: lessons from EPICA Eur J Heart Fail, October 1, 2004; 6(6): 793 - 794. [Full Text] [PDF]
|
|
|
|
|
|
F. Ceia, C. Fonseca, T. Mota, H. Morais, F. Matias, C. Costa, and A. G. Oliveira Aetiology, comorbidity and drug therapy of chronic heart failure in the real world: the EPICA substudy Eur J Heart Fail, October 1, 2004; 6(6): 801 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P.M van Empel and L. J De Windt Myocyte hypertrophy and apoptosis: a balancing act Cardiovasc Res, August 15, 2004; 63(3): 487 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Bax, G. Ansalone, O. A. Breithardt, G. Derumeaux, C. Leclercq, M. J. Schalij, P. Sogaard, M. St. John Sutton, and P. Nihoyannopoulos Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use?: A critical appraisal J. Am. Coll. Cardiol., July 7, 2004; 44(1): 1 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tendera The epidemiology of heart failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1_suppl): S2 - S6. [Abstract] [PDF]
|
|
|
|
|
|
M. Metra, S. Nodari, and L. Dei Cas Current guidelines in the pharmacological management of chronic heart failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1_suppl): S11 - S16. [Abstract] [PDF]
|
|
|
|
 |
|
 E. van Rooij, P. A. Doevendans, H. J.G.M. Crijns, S. Heeneman, D. J. Lips, M. van Bilsen, R. S. Williams, E. N. Olson, R. Bassel-Duby, B. A. Rothermel, et al. MCIP1 Overexpression Suppresses Left Ventricular Remodeling and Sustains Cardiac Function After Myocardial Infarction Circ. Res., February 20, 2004; 94 (3): e18 - e26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Dowling, L. A. Gray Jr, S. W. Etoch, H. Laks, D. Marelli, L. Samuels, J. Entwistle, G. Couper, G. J. Vlahakes, and O. H. Frazier Initial experience with the AbioCor Implantable Replacement Heart System J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 131 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Ng, I. Loke, J. E. Davies, K. Khunti, M. Stone, K. R. Abrams, D. T. Chin, and I. B. Squire Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography Eur J Heart Fail, December 1, 2003; 5(6): 775 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. F. Cleland and A. L. Clark Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: Too many cooks will spoil the broth J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1234 - 1237. [Full Text] [PDF]
|
|
|
|
|
|
M. Ledwidge, M. Barry, J. Cahill, E. Ryan, B. Maurer, M. Ryder, B. Travers, L. Timmons, and K. McDonald Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care? Eur J Heart Fail, June 1, 2003; 5(3): 381 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.G.F Cleland, K Swedberg, F Follath, M Komajda, A Cohen-Solal, J.C Aguilar, R Dietz, A Gavazzi, R Hobbs, J Korewicki, et al. The EuroHeart Failure survey programme--a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis Eur. Heart J., March 1, 2003; 24(5): 442 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. O. Weinberg, M. Shimpo, S. Hurwitz, S.-i. Tominaga, J.-L. Rouleau, and R. T. Lee Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker Circulation, February 11, 2003; 107(5): 721 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Ibrahim The frequency of systolic versus diastolic heart failure in an Egyptian cohort Eur J Heart Fail, January 1, 2003; 5(1): 41 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.G.F. Cleland, A. Takala, M. Apajasalo, N. Zethraeus, and G. Kobelt Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial Eur J Heart Fail, January 1, 2003; 5(1): 101 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. van Rooij, P. A. Doevendans, C. C. de Theije, F. A. Babiker, J. D. Molkentin, and L. J. De Windt Requirement of Nuclear Factor of Activated T-cells in Calcineurin-mediated Cardiomyocyte Hypertrophy J. Biol. Chem., December 6, 2002; 277(50): 48617 - 48626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J G F Cleland Contemporary management of heart failure in clinical practice Heart, October 1, 2002; 88(90002): ii5 - 8. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||